Cladribine

Brand name: Mavenclad

Rank #444 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$17.5M

Total Cost

Share:

228

Total Claims

$17.5M

Total Cost

13

Prescribers

$77K

Cost per Claim

60

Beneficiaries

422

30-Day Fills

$1.3M

Avg Cost/Provider

18

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$17.5M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $17.5M total

🔎 Data Overview

💰

At $76,718 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $1,345,520 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

👤

Average cost of $291,529 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Cladribine

#ProviderSpecialtyLocationClaimsCost
1Amparo GutierrezNeurologyOrlando, FL41$3.2M
2Roberto Cruz SaldanaNeurologyMcallen, TX25$2.0M
3Bruce HughesNeurologyDes Moines, IA22$1.8M
4Randall TrudellNeurologyKnoxville, TN21$1.7M
5Anthony SharpPhysician AssistantOklahoma City, OK17$1.3M
6Donald NegroskiNeurologySarasota, FL17$1.3M
7Haylie DayNurse PractitionerGreenbrier, AR12$964K
8Brian SteingoNeurologyBoca Raton, FL13$948K
9Harold MosesNeurologyNashville, TN12$948K
10John HemphillNeurologySavannah, GA13$934K
11Carlos MoraNeurologyRoanoke, VA13$832K
12Gary BeaverNeurologyDuluth, MN11$755K
13Ryan ShannonNurse PractitionerMontgomery, AL11$707K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
441Rufinamide (Rufinamide)$18.0M8,793
442Istradefylline (Nourianz)$17.8M7,061
443Encorafenib (Braftovi)$17.6M1,209
444Cladribine (Mavenclad)$17.5M228
445Enalapril Maleate (Enalapril Maleate)$17.5M673,317
446Vismodegib (Erivedge)$17.4M1,317
447Anastrozole (Anastrozole)$17.4M626,025

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology